Description: The Asian insurance landscape is undergoing significant change, with Japan experiencing a surge in reinsurance activity. This webcast will explore the factors driving this growth and provide insights into the current state and future direction of the Japanese reinsurance market. We'll delve into the unique characteristics of the Japanese market, examining the specific reinsurance needs of Japanese life insurers and how partnerships with US and offshore reinsurers are evolving. Looking ahead, we'll analyze the expected trajectory of the market, including the types of business and products likely to see increased demand. We'll also discuss how emerging economic factors and regulatory changes will shape future needs and the competitive landscape. Join us to gain valuable insights into this dynamic market and its future potential.

Description: This video from Ben Keslowitz explains the concept of reinsurance, which is a financial arrangement where insurance companies transfer portions of their risk portfolios to other parties, known as reinsurers. This helps insurers manage large or catastrophic claims and optimize their risk components. The video also covers different types of reinsurance, such as proportional liability reinsurance, non-proportional reinsurance, and quota share coinsurance, each serving different purposes in risk management. Additionally, it discusses the reasons insurers might choose to reinsure their business, including liability risk mitigation, investment risk transfer, and entering new markets.

Description: This three-part series provides an overview of the rapidly evolving and dynamic gene and cellular therapy landscape, from the clinical, historical, and risk transfer perspectives. It covers the actuarial considerations in pricing cell and gene insurance and reinsurance, the value assessment of the therapies, manufacturer pricing, and reinsurance cost.

Description: Attend this webcast to learn more on how to navigate managing ESG principles in the new normal of a post-COVID world. Enhance your ESG insights in a post-pandemic landscape.

Description: This three-part series provides an overview of the rapidly evolving and dynamic gene and cellular therapy landscape, from the clinical, historical, and risk transfer perspectives. It covers the actuarial considerations in pricing cell and gene insurance and reinsurance, the value assessment of the therapies, manufacturer pricing, and reinsurance cost.

Description: In this webcast, the attendee will get an introduction regarding the major global group capital framework including but not limited to: 1. The history of group capital framework 2. Introduction to various group capital framework such as Solvency II, Bermuda EBS, Group Capital Calculations, and Insurance Capital Standard

Description: Equity-Based Insurance Guarantee Webcast Series

Description: This introduction to Captive Insurance Companies will provide an overview that includes the history of captives, different types of captives, common applications, how captives work, why employers form or join a captive, and a Medical Stop Loss Group Captive case study.